Alzheimer`s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD): Accelerating Drug Discovery for Frontotemporal Degeneration (LOI)

Priority Areas

-Development and testing of novel high throughput screening assays

-Identification and in vitro testing of potentially disease modifying compounds or biologics, including medicinal chemistry refinement, ADME, toxicology, pharmacokinetics, and pharmacodynamics studies

-Testing of novel lead compounds, biologics, or repurposed drug candidates in a relevant animal model for preclinical proof of concept

-Development and/or characterization of new model organisms or cellular models to support drug discovery efforts.

Funding:  $100,000-$150,000 for 1 year.

https://www.alzdiscovery.org/research-and-grants/funding-opportunities/accelerating-drug-discovery-for-ftd